As a specific inhibitor of PGK1,23 CBR‐470‐1 can significantly reduce the increase in PGK1 activity caused by hypoxia and reduce the activity of NLRP3, inducing a significant anti‐arthritis effect. Here, PGK1 is linked to arthritic joint disease.